Home JournalsJournal Details

ISSN: 2059-3635 eISSN: 2095-9907 CAS Zone: Medicine (Zone 1) Emerging Zone: Medicine (Zone 1)

Signal Transduction and Targeted Therapy

Abbr. SIGNAL TRANSDUCT TAR

81.2

Latest IF

Recent Articles

Polymeric alpha-1 antitrypsin perturbs Paneth cell proteostasis and exacerbates intestinal inflammation

Annunziata F, Dos Santos Matos F, Relvini I et al · Vol 11(1)

2026-09-28

Transcriptional intermediary factor 1 gamma-based multitarget gene therapeutic strategy for triple-negative breast cancer

Park H, Kim T, Yun H et al · Vol 11(1)

2026-09-28

Transketolase-like 1 potentiates PD-1 blockade in hepatocellular carcinoma by glycolysis to prime dendritic cell lactylation

Cao H, Huang T, Chai Y et al · Vol 11(1)

2026-09-27

Artificial intelligence in biomarker discovery for diseases: diagnostic and therapeutic prospects

Dinc R, Ardic N · Vol 11(1)

2026-09-24

Inotodiol prevents age-related muscle wasting by restoring mitochondrial function through liver X receptor beta signaling

You C, Bae J, Jeong Y et al · Vol 11(1)

2026-09-24

Keeping forks in the loop: how chromatin architecture shields stalled replication forks

Ghaddar N, Downs J · Vol 11(1)

2026-09-24

Correction: Extracellular matrix-derived mechanical force governs breast cancer cell stemness and quiescence transition through integrin-DDR signaling

Li C, Qiu S, Liu X et al · Vol 11(1)

2026-09-24

RNA therapeutics: current status and future directions

Yang B, Sedano M, Perez K et al · Vol 11(1)

2026-09-24

Inhibition of USP2 suppresses pathological pexophagy and rescues PEX1-deficient peroxisome biogenesis disorder

Kim Y, Jo D, Kim A et al · Vol 11(1)

2026-09-23

Synthetic lethality in cancer: mechanisms, therapeutic exploitation and clinical translation

Camps-Fajol C, Minguillón J, Surrallés J · Vol 11(1)

2026-09-23

Heterogeneity in cancer: molecular mechanisms and therapeutic strategies

He Y, Niu L, Ren Y et al · Vol 11(1)

2026-09-23

Cuproptosis and ferroptosis: signal pathways, diseases and therapeutic targets

Li Y, Tay F · Vol 11(1)

2026-09-23

Targeting BIRC6 rejuvenates hematopoietic stem cell aging and immunosenescence

Liao W, Shao F, Wang S et al · Vol 11(1)

2026-09-23

Antibody-drug conjugate engineering: from design to efficacy and safety

Ocana A, Espinosa J, Alonso-Moreno C et al · Vol 11(1)

2026-09-23

Retinoic acid in health and disease

De Angelis M, Dattilo V, Vono N et al · Vol 11(1)

2026-09-22

Fracture healing: from molecular and cellular mechanisms to therapeutic strategies

Staubli F, ten Ham R, Bergsma J et al · Vol 11(1)

2026-09-21

Cell death: immunogenic potential of cuproptosis in cancer

Galluzzi L, Kepp O, Kroemer G · Vol 11(1)

2026-09-21

Correction: Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies

Xu G, Jin J, Fu Z et al · Vol 11(1)

2026-09-21

HSP90 shields ROC1/RBX1 from proteasomal degradation by CHIP E3 ubiquitin ligase to promote lung adenocarcinoma

Li L, Zhang Y, Li M et al · Vol 11(1)

2026-09-21

Inhibition of CDK/Cyclin-phospho-Rb signaling by amebaciclib may have an antitumor effect against uterine leiomyosarcoma

Hayashi T, Muto M, Konishi I · Vol 11(1)

2026-09-20

Journal Info

ISSN

2059-3635

Abbr.

SIGNAL TRANSDUCT TAR

CAS Zone

Medicine (Zone 1) · Top

Emerging Zone

Medicine (Zone 1) · Non-Top

Sub-categories

BIOCHEMISTRY & MOLECULAR BIOLOGYZone 1CELL BIOLOGYZone 1

Emerging Categories

BIOCHEMISTRY & MOLECULAR BIOLOGYZone 1CELL BIOLOGYZone 1

Analysis Services

Signal Transduction and Targeted Therapy

Contact

WeChat Official Account